Michael W Conner

Title: The Innovations of Michael W. Conner

Introduction

Michael W. Conner is a notable inventor based in Half Moon Bay, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize glycopeptide antibiotics. With a total of five patents to his name, Conner's work has the potential to impact the treatment of bacterial diseases in mammals.

Latest Patents

Among his latest patents, Conner has developed pharmaceutical compositions that contain a glycopeptide antibiotic and a cyclodextrin. These compositions are designed to provide a therapeutically effective amount of the antibiotic or its salt. The methods disclosed in these patents focus on treating bacterial diseases in mammals through the administration of these innovative pharmaceutical formulations.

Career Highlights

Conner is currently associated with Theravance, Inc., where he continues to advance his research and development efforts. His work at Theravance has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include J. Kevin Judice and YongQi Mu. Their collaborative efforts contribute to the innovative environment at Theravance, fostering advancements in pharmaceutical research.

Conclusion

Michael W. Conner's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective treatments. His patents reflect a deep understanding of the complexities involved in combating bacterial diseases, showcasing his role as a leading inventor in the industry.